Ultra Midcap 400 Proshares Index (Intraday Indicative Value)
Index Chart
From Jul 2019 to Jul 2024
![Click Here for more Ultra Midcap 400 Proshares Index (Intraday Indicative Value) Charts. Click Here for more Ultra Midcap 400 Proshares Index (Intraday Indicative Value) Charts.](/p.php?pid=staticchart&s=A%5EMXR&p=8&t=15)
HealthRamp RxPricePoint(TM) to Provide Competitive Drug Pricing on a Handheld
Device at the Point of Care
Patent Pending Technology to Cover Innovation in Electronic Prescribing
NEW YORK, Dec. 10 /PRNewswire-FirstCall/ -- Medix Resources, Inc. today
announced that its HealthRamp CarePoint(TM) technology is being extended to
deliver its RxPricePoint program at the point of prescribing on a handheld
device. HealthRamp's patent pending RxPricePoint technology will enable pricing
data to be gathered from pharmacies to provide physicians with the lowest cost
pharmacy option for a given patient at the point of care. Medix, through its
wholly owned HealthRamp subsidiary, markets the CarePoint suite of
technologies.
RxPricePoint lets physicians show their patients the pharmacy, mail order or
retail, where they can locate the lowest priced drugs for their prescription.
Physicians will also be able to inform their patients of the pharmacy with the
best price for fulfilling any portfolio of prescriptions. Pharmacies
participating in the program will pay HealthRamp a transaction fee for every
prescription filled through RxPricePoint. Patients will be able to utilize the
HealthRamp website to search for the lowest cost drugs in their area, enabling
them to proactively deliver this information to their physicians. Further
information about RxPricePoint will be available on our website, at
http://www.healthramp.com/rxpricepoint , and it is expected that RxPricePoint
will be made available by the end of the first quarter of 2004.
"Using the free market to bring down the price of drugs is extremely important,"
according to Nevada State Senator Ray Rawson. Rawson, a veteran Nevada
legislator and a dentist, works with state governments across the country on
reform measures. "Legislatures should begin looking at ways to assist
pharmacies and drug stores in the regular posting of their prescription drug
prices. We now have everyday technology that can bring those prices right into
the physician's office and directly into the hands of patients," stated Rawson.
"This full disclosure of retail prices will create an instant competitive
environment that should result in a significant savings to patients and
taxpayers," concluded Rawson.
"By providing drug pricing data at the point of care, RxPricePoint should over
time lower the cost of prescription drugs to society as a whole. The
opportunity to present real-time pricing data will allow pharmacies to better
market themselves and manage their operations more efficiently. CarePoint is
the link to the physician, over which we expect many healthcare innovations to
evolve," stated Darryl Cohen, Medix CEO and Chairman.
Medix, through its wholly owned HealthRamp subsidiary, markets the CarePoint
suite of technologies. CarePoint enables electronic prescribing, lab orders and
results, Internet-based communication, data integration, and transaction
processing over a handheld device or browser, at the point-of- care. The
combination of these technologies is designed to provide access to safer and
better healthcare. Medix's products enable communication of high value-added
healthcare information among physician offices, pharmacies, hospitals, pharmacy
benefit managers, health management organizations, pharmaceutical companies and
health insurance companies. Additional information about HealthRamp, and its
products and services, can be found at http://www.healthramp.com/ .
Safe Harbor Statement: To the extent that any statements made in this press
release contain information that is not historical, these statements are
essentially forward-looking. Forward-looking statements can be identified by
the use of words such as "expects," "plans," "will," "may," "anticipates,"
"believes," "should," "intends," "estimates," and other words of similar
meaning. These statements are subject to risks and uncertainties that cannot be
predicted or quantified and, consequently, actual results may differ materially
from those expressed or implied by such forward-looking statements. Such risks
and uncertainties include, without limitation, the ability of Medix to raise
capital to finance the development of its Internet services and related
software, the effectiveness, profitability and the marketability of those
services, the ability of the Company to protect its proprietary information and
to retain and expand its user base, the establishment of an efficient corporate
operating structure as the Company grows and, other risks detailed from
time-to-time in our filings with the Securities and Exchange Commission. The
Company undertakes no obligation to publicly update any forward-looking
statements.
DATASOURCE: Medix Resources, Inc.
CONTACT: Investors, Andrew Brown, +1-212-697-2509, or Media, Robin
Schoen, +1-215-504-2122, both Medix Resources, Inc.
Web site: http://www.healthramp.com/rxpricepoint
Web site: http://www.healthramp.com/
Web site: http://www.medixresources.com/